Journal: Cellular signalling
Article Title: Enzymatic cleavage of myoferlin releases a dual C2-domain module linked to ERK signalling
doi: 10.1016/j.cellsig.2017.02.009
Figure Lengend Snippet: Evaluation of predicted calpain-cleavage sites in myoferlin. A) In vitro cleavage of dysferlin and myoferlin constructs immunopurified from transfected HEK293 cells and incubated with recombinant calpain-1. Protein-bound Sepharose beads were incubated in buffer containing 2 mM CaCl2 in the presence of purified 0.2 A.U. of recombinant calpain-1 at 30 °C for 10 or 120 s, or in the absence of calpain (−). Proteolysis was rapidly inhibited by reconstitution of the reaction in SDS lysis buffer and heating to 94 °C. Digested samples were analyzed by SDS–PAGE and western blot. B) In cell cleavage of dysferlin and myoferlin expression constructs is induced via scrape-harvesting of transfected HEK293 cells. (+) with scrape injury in +Ca2+- PBS; (−) without scrape injury, harvested directly into ice-cold RIPA buffer with EDTA. Dysferlin without a calpain cleavage site (DFL) is not cleaved. Dysferlin with exon 40a (D40a) is cleaved by recombinant calpain (A) and during scrape-harvesting (B). Both predicted myoferlin cleavage sites in exon 38 and exon 38a can functionally substitute for exon 40a in in vitro and in cell cleavage assays (DM38, DM38a). Myoferlin (MFL) is cleaved by calpain-1 in vitro (A) and is cleaved independently of scrape injury in transfected HEK293 (B). Substitution of myoferlin exon 38 with the corresponding residues from dysferlin (encoded by exon 40; MD40) prevents cleavage, confirming myoferlin exon 38 sequences contain a cleavage motif. Paradoxically, myoferlin constructs with exon 38a (M38a) are not cleaved in vitro or in cells. Inclusion of exon 38a sequences regulates (precludes) cleavage both within exon 38a as well as at the exon 38 site.
Article Snippet: Constructs The dysferlin cDNA construct (EGFP-FL-DYSF pcDNA3.1, National Center for Biotechnology Information [NCBI] reference sequence NP_003485.1 ) was a generous gift from Kate Bushby (Institute of Human Genetics, International Centre for Life, Newcastle upon Tyne, UK), and was subcloned into pIRES2-EGFP (OriGene).
Techniques: In Vitro, Construct, Transfection, Incubation, Recombinant, Purification, Lysis, SDS Page, Western Blot, Expressing